Genetics, epigenetics, and pregenetics.

Int J Yoga

Swami Vivekananda Yoga Anusandhana Samsthana (A Yoga University), No. 9, Appajappa Agrahara, Chamarajpet, Bangalore - 560 018, India. E-mail:

Published: July 2011

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193653PMC
http://dx.doi.org/10.4103/0973-6131.85484DOI Listing

Publication Analysis

Top Keywords

genetics epigenetics
4
epigenetics pregenetics
4
genetics
1
pregenetics
1

Similar Publications

Mutations or homozygous deletions of MHC class II (MHC-II) genes are commonly found in B cell lymphomas that develop in immune-privileged sites and have been associated with patient survival. However, the mechanisms regulating MHC-II expression, particularly through genetic and epigenetic factors, are not yet fully understood. In this study, we identified a key signaling pathway involving the histone H2AK119 deubiquitinase BRCA1 associated protein 1 (BAP1), the interferon regulatory factor interferon regulatory factor 1 (IRF1), and the MHC-II transactivator class II transactivator (CIITA), which directly activates MHC-II gene expression.

View Article and Find Full Text PDF

Optimized circular RNA vaccines for superior cancer immunotherapy.

Theranostics

January 2025

Department of Integrative Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.

Circular RNA (circRNA) has gained attention as a promising platform for mRNA vaccines due to its stability, sustained protein expression, and intrinsic immunostimulatory properties. This study aimed to design and optimize a circRNA cancer vaccine platform by screening for efficient internal ribosome entry sites (IRES) and enhancing circRNA translation efficiency for improved cancer immunotherapy. We screened 29 IRES elements to identify the most efficient one for immune cell translation, ultimately discovering the A (EV-A) IRES.

View Article and Find Full Text PDF

Targeting KAT7 inhibits the progression of colorectal cancer.

Theranostics

January 2025

Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China.

Colorectal cancer (CRC) is a leading cause of cancer-related mortality. Epigenetic modifications play a significant role in the progression of CRC. KAT7, a histone acetyltransferase, has an unclear role in CRC.

View Article and Find Full Text PDF

Alzheimer's disease (AD) is the most frequent form of dementia and represents an increasing global burden, particularly in countries like Indonesia, where the population has begun to age significantly. Current medications, including cholinesterase inhibitors and NMDA receptor antagonists, have modest effects on clinical symptoms in the early to middle stages, but there is no curative treatment available so far despite progress. Activating or repressing epigenetic modifications, including DNA methylation, histone modification and microRNA regulation, appears to play an important role in AD development.

View Article and Find Full Text PDF

Climate change and epigenetics: Unraveling the role of methylation in response to thermal instability in the Antarctic plant Colobanthus quitensis.

Physiol Plant

January 2025

Centro de Ecología Integrativa (CEI), Instituto de Ciencias Biológicas, Universidad de Talca, Talca, Chile.

Low temperatures are one of the critical conditions affecting the performance and distribution of plants. Exposure to cooling results in the reprogramming of gene expression, which in turn would be mediated by epigenetic regulation. Antarctica is known as one of the most severe ecosystems, but several climate models predict an increase in average temperature, which may positively impact the development of Antarctic plants; however, under warmer temperatures, plants' vulnerability to damages from low-temperature events increases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!